Femara
Drug - Femara
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Letrozole
Multiple ingredients are in alphabetical order.
Strength -
2.5MG
The potency of the active ingredient(s), Letrozole. May repeat for multiple part products.
Applicant -
NOVARTIS
The firm name holding legal responsibility for Femara. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
020726
The FDA assigned number to Femara. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Femara. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jul 25, 1997
The date Femara was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
Yes
The pioneer or innovator of Femara. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
RX
The group or category of approved drugs Femara is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Femara.
Femara
|
